EGF816 and Trametinib in Patients With Non-small Cell Lung Cancer Harboring Activating EGFR Mutations
Clinical trial NCT03516214 · COMPLETED
Trial details
- NCT number
- NCT03516214
- Sponsor
- University of Cologne
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-25
- Primary completion
- 2022-09-30
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.